{"id":66051,"date":"2018-03-21T13:37:22","date_gmt":"2018-03-21T12:37:22","guid":{"rendered":"https:\/\/uniavisen.dk\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/"},"modified":"2018-03-21T13:37:22","modified_gmt":"2018-03-21T12:37:22","slug":"patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability","status":"publish","type":"event","link":"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/","title":{"rendered":"Patenting Natural Products: Myriad and Modern Medicine- A Comparative Perspective on Patentability"},"content":{"rendered":"<p><em>Rochelle Dreyfuss<\/em><br \/>\n<em> Pauline Newman Professor of Law at the NYU School of Law<\/em><br \/>\n<em> Co-Director, Engelberg Center on Innovation Law &amp; Policy <\/em><br \/>\n<em> Co-Director, Competition, Innovation, and Information Law Program<\/em><\/p>\n<p>On April 5, 2018, CeBIL will host Rochelle Dreyfus. The topic of discussion will be Dreyfuss\u2019s paper with Dianne Nicol \u2018Patenting Natural Products: Myriad and Modern Medicine- A Comparative Perspective on Patentability.\u2019 \u00a0The paper examines the Myriad decisions in the United States and Australia, which bar patents on naturally occurring products &#8211; specifically, on isolated genes. These decisions leave many open questions on the patentability of products and processes that duplicate (or come close to duplicating) material found in nature. They release material for free use by researchers and for patient care. However, they also endanger the future of privately-supported research in the life sciences.\u00a0 The two decisions are, however, not identical and their local impact also appears to be considerably different. Dreyfuss\u2019s paper will explore these differences.\u00a0 First, an examination of whether the Australian decision suggests limiting principles is presented: a path to a patent law that deals more successfully with dual-use technologies (inventions that are simultaneously research inputs and commercial outputs). Secondly, the paper looks at the factors in Australian practice that ameliorated the effects of gene patenting prior to the decision in Myriad and suggests ways in which US law could better reflect those factors to create greater certainty for all stakeholders.<\/p>\n<p><a href=\"http:\/\/jura.ku.dk\/cebil\/calendar\/patenting-natural-products\/\"><strong>Read more and sign up<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rochelle Dreyfuss Pauline Newman Professor of Law at the NYU School of Law Co-Director, Engelberg Center on Innovation Law &amp; Policy Co-Director, Competition, Innovation, and Information Law Program On April 5, 2018, CeBIL will host Rochelle Dreyfus. The topic of discussion will be Dreyfuss\u2019s paper with Dianne Nicol \u2018Patenting Natural Products: Myriad and Modern Medicine- [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":66052,"template":"","class_list":["post-66051","event","type-event","status-publish","has-post-thumbnail","hentry","event_category-seminar"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Patenting Natural Products: Myriad and Modern Medicine- A Comparative Perspective on Patentability<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Patenting Natural Products: Myriad and Modern Medicine- A Comparative Perspective on Patentability\" \/>\n<meta property=\"og:description\" content=\"Rochelle Dreyfuss Pauline Newman Professor of Law at the NYU School of Law Co-Director, Engelberg Center on Innovation Law &amp; Policy Co-Director, Competition, Innovation, and Information Law Program On April 5, 2018, CeBIL will host Rochelle Dreyfus. The topic of discussion will be Dreyfuss\u2019s paper with Dianne Nicol \u2018Patenting Natural Products: Myriad and Modern Medicine- [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/\" \/>\n<meta property=\"og:site_name\" content=\"University Post\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/uniavis\" \/>\n<meta property=\"og:image\" content=\"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1251\" \/>\n\t<meta property=\"og:image:height\" content=\"1378\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Uniavisen\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/event\\\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\\\/\",\"url\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/event\\\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\\\/\",\"name\":\"Patenting Natural Products: Myriad and Modern Medicine- A Comparative Perspective on Patentability\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/event\\\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/event\\\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/uniavisen.dk\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/dreyfuss1.jpg\",\"datePublished\":\"2018-03-21T12:37:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/event\\\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/uniavisen.dk\\\/en\\\/event\\\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/event\\\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\\\/#primaryimage\",\"url\":\"https:\\\/\\\/uniavisen.dk\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/dreyfuss1.jpg\",\"contentUrl\":\"https:\\\/\\\/uniavisen.dk\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/dreyfuss1.jpg\",\"width\":1251,\"height\":1378},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/event\\\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/uniavisen.dk\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\\\/\\\/uniavisen.dk\\\/event\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Patenting Natural Products: Myriad and Modern Medicine- A Comparative Perspective on Patentability\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/uniavisen.dk\\\/#website\",\"url\":\"https:\\\/\\\/uniavisen.dk\\\/\",\"name\":\"University Post\",\"description\":\"Independent of management\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/uniavisen.dk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Patenting Natural Products: Myriad and Modern Medicine- A Comparative Perspective on Patentability","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/","og_locale":"en_US","og_type":"article","og_title":"Patenting Natural Products: Myriad and Modern Medicine- A Comparative Perspective on Patentability","og_description":"Rochelle Dreyfuss Pauline Newman Professor of Law at the NYU School of Law Co-Director, Engelberg Center on Innovation Law &amp; Policy Co-Director, Competition, Innovation, and Information Law Program On April 5, 2018, CeBIL will host Rochelle Dreyfus. The topic of discussion will be Dreyfuss\u2019s paper with Dianne Nicol \u2018Patenting Natural Products: Myriad and Modern Medicine- [&hellip;]","og_url":"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/","og_site_name":"University Post","article_publisher":"https:\/\/www.facebook.com\/uniavis","og_image":[{"width":1251,"height":1378,"url":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@Uniavisen","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/","url":"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/","name":"Patenting Natural Products: Myriad and Modern Medicine- A Comparative Perspective on Patentability","isPartOf":{"@id":"https:\/\/uniavisen.dk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/#primaryimage"},"image":{"@id":"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/#primaryimage"},"thumbnailUrl":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1.jpg","datePublished":"2018-03-21T12:37:22+00:00","breadcrumb":{"@id":"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/#primaryimage","url":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1.jpg","contentUrl":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1.jpg","width":1251,"height":1378},{"@type":"BreadcrumbList","@id":"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/uniavisen.dk\/en\/"},{"@type":"ListItem","position":2,"name":"Events","item":"https:\/\/uniavisen.dk\/event\/"},{"@type":"ListItem","position":3,"name":"Patenting Natural Products: Myriad and Modern Medicine- A Comparative Perspective on Patentability"}]},{"@type":"WebSite","@id":"https:\/\/uniavisen.dk\/#website","url":"https:\/\/uniavisen.dk\/","name":"University Post","description":"Independent of management","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/uniavisen.dk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"advancedCustomFields":{"event_category":{"term_id":72,"name":"Seminar","slug":"seminar","term_group":0,"term_taxonomy_id":72,"taxonomy":"event_category","description":"","parent":0,"count":337,"filter":"raw"},"start":"2018-04-05 16:00:00","add_end_time":true,"end":"2018-04-05 17:30:00","location":"Meeting box. 2nd floor, room 7A-2-04, Njalsgade 76, DK-2300 Copenhagen S","host_name":"CeBIL - Center for Advanced Studies in Biomedical Innovation Law ","ticket_link":"http:\/\/jura.ku.dk\/cebil\/calendar\/patenting-natural-products\/registration\/","event_is_free":true,"event_poster":{"ID":66052,"id":66052,"title":"dreyfuss1.jpg","filename":"dreyfuss1.jpg","filesize":152265,"url":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1.jpg","link":"https:\/\/uniavisen.dk\/en\/event\/patenting-natural-products-myriad-and-modern-medicine-a-comparative-perspective-on-patentability\/dreyfuss1-jpg\/","alt":"","author":"0","description":"","caption":"","name":"dreyfuss1-jpg","status":"inherit","uploaded_to":66051,"date":"2018-03-21 12:37:22","modified":"2018-03-21 12:37:23","menu_order":0,"mime_type":"image\/jpeg","type":"image","subtype":"jpeg","icon":"https:\/\/uniavisen.dk\/wp-includes\/images\/media\/default.png","width":1251,"height":1378,"sizes":{"thumbnail":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1-150x150.jpg","thumbnail-width":150,"thumbnail-height":150,"medium":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1-480x529.jpg","medium-width":480,"medium-height":529,"medium_large":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1-768x846.jpg","medium_large-width":768,"medium_large-height":846,"large":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1.jpg","large-width":1251,"large-height":1378,"1536x1536":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1.jpg","1536x1536-width":1251,"1536x1536-height":1378,"2048x2048":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1.jpg","2048x2048-width":1251,"2048x2048-height":1378,"featured-soft":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1-290x319.jpg","featured-soft-width":290,"featured-soft-height":319,"featured-hard":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1-290x180.jpg","featured-hard-width":290,"featured-hard-height":180,"narrow":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1-700x771.jpg","narrow-width":700,"narrow-height":771,"extended":"https:\/\/uniavisen.dk\/wp-content\/uploads\/2018\/03\/dreyfuss1-990x1091.jpg","extended-width":990,"extended-height":1091}},"short_description":"CeBIL seminar with Rochelle Dreyfuss from NYU School of Law on 5 April. Dreyfuss will discuss her paper \u2018Patenting Natural Products: Myriad and Modern Medicine- A Comparative Perspective on Patentability.\u2019 ","old_url":""},"_links":{"self":[{"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/events\/66051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/events"}],"about":[{"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/types\/event"}],"version-history":[{"count":0,"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/events\/66051\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/media\/66052"}],"wp:attachment":[{"href":"https:\/\/uniavisen.dk\/en\/wp-json\/wp\/v2\/media?parent=66051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}